Danilo Verge

Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation.

Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation.

Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation.

Viewmind, Inc. is a digital health and artificial intelligence company based in an undisclosed location. The American company provides clinically validated solutions for the early diagnosis of cognitive diseases. Viewmind has developed a unique, reliable, non-invasive, affordable, and accessible digital biomarker technology that delivers clinical results as accurate as today's definitive tests and is viable for early screening at scale. Viewmind's diagnostic solutions analyze eye movement patterns, which is considered cognitive health data in its purest form. The company's tools can unlock cognitive potential and achieve extraordinary mental breakthroughs. Viewmind's comprehensive research delves into the scientific principles behind cognitive enhancement. The company was founded by Matias Shulz, Gerardo Fernandez, and Mark Edwards, with Mark Edwards serving as the CEO since incorporation.